O
Oluwasegun Afolaranmi
Researcher at University of Ibadan
Publications - 6
Citations - 64
Oluwasegun Afolaranmi is an academic researcher from University of Ibadan. The author has contributed to research in topics: Cancer & Case fatality rate. The author has an hindex of 2, co-authored 5 publications receiving 15 citations. Previous affiliations of Oluwasegun Afolaranmi include University of Lagos.
Papers
More filters
Journal ArticleDOI
COVID-19 Pandemic: Is Africa Different?
Ebun L. Bamgboye,Jesutofunmi A. Omiye,Oluwasegun Afolaranmi,Mogamat Razeen Davids,Elliot Koranteng Tannor,Shoyab Wadee,Abdou Niang,Anthony J.O. Were,Saraladevi Naicker +8 more
TL;DR: Information presented in this review will help policymakers in the fight to contain the pandemic, particularly within Africa with its resource-constrained health care systems.
Journal ArticleDOI
Cancer presentation patterns in Lagos, Nigeria: Experience from a private cancer center
Abimbola Fapohunda,Adeola Fakolade,Jesutofunmi A. Omiye,Oluwasegun Afolaranmi,Oreoluwa Arowojolu,Tunde A. Oyebamiji,Chukwumere Nwogu,Alexander Olawaiye,Jimoh Mutiu +8 more
TL;DR: In this article, the characteristics of patients that presented to a private cancer center in Lagos, Nigeria were assessed using data from a hospital-based registry, and the most common cancer types were breast cancer for females (46%) and prostate cancer for males (32%).
Journal ArticleDOI
Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria.
Omolola Salako,Kehinde S Okunade,Adeoluwa Akeem Adeniji,Gabriel T. Fagbenro,Oluwasegun Afolaranmi +4 more
TL;DR: In this paper, a prospective cross-sectional study was conducted among 113 female chemotherapy-naive breast cancer patients over a 2-year period, which assessed the incidence of chemotherapy-induced neutropenia and febrile neutropensia while identifying their associated factors.
Journal ArticleDOI
Totally implantable venous access ports and associated complications in sub-Saharan Africa: a single-centre retrospective analysis
Kahmil O Salawu,O.A. Arowojolu,Oluwasegun Afolaranmi,Mutiu Jimoh,Chukwumere Nworgu,Bode Falase +5 more
TL;DR: The study shows that TIVAPs can be used successfully in the authors' environment and presents a case for more widespread use to improve both the patient experience and the ability of healthcare providers to deliver optimal treatment.
Journal ArticleDOI
Aggressive mycosis fungoides/sézary syndrome in Nigeria: case report and literature review
TL;DR: A case of fatal aggressive mycosis fungoides/sezary syndrome is reported in a 55-year old Nigerian man who initially developed pruritic hyperpigmented spots on his skin which progressed over the course of 5 years to widespread scaly mixed hyperPigmented and hypopigmented plaques and nodules with features of organ involvement despite being managed with Psoralen and ultraviolet A radiation.